Unlock regulatory insights with Watson. Learn More

Draft Guidance for Industry on ANDA Submissions; Content and Format of Abbreviated New Drug Applications; Availability

Center CDER
VIEW ALL (2)Primary Documents
VIEW ALL (14) Comments